Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 4, 1999, Pages 999-1003

  Aref, Amr ^a   Yudelev, Mark ^a   Mohammad, Ramzi ^a   Choudhuri, Rajani ^a   Orton, Colin ^a   Al Katib, Ayad ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Lymphoma cell lines; Neutron radiotherapy; Non Hodgkin lymphoma

Indexed keywords

ARTICLE; CELL LINE; COBALT THERAPY; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL; NEUTRON RADIATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0032741890     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00258-8     Document Type: Article

References (34)

1. Laramore GE, Krall JM, Griffin TW; et al. Neutron versus photon irradiation for unresectable salivary gland tumor: Final report of an RTOG-MRC randomized clinical trial. Int J Radiat Oncol Biol Phys 1993;30:27:235-240.
2. Russell K.J., Caplan R.J., Laramore G.E., et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer Results of a randomized prospective trial . Int J Radiat Oncol Biol Phys. 28:1994;47-54.
3. Schwarz R., Krull A., Lessel A., et al. European results of neutron therapy in soft tissue sarcomas. Recent Results Cancer Res. 150:1998;100-112.
4. Hoppe R. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer. 55:1985;2176-2183.
5. Hallahan D.E., Farah R., Voles E.E., et al. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 17:1989;767-771.
6. Levitt S., Lee C., Bloomfield C., et al. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol. 3:1985;33-37.
7. Lichter A.S., Tracy D., Lam W.-C., et al. Total body irradiation in bone marrow transplantation the influence of fractionation and delay of marrow infusion . Int J Radiat Oncol Biol Phys. 6:1979;301-309.
8. 50 and the survival of bone-marrow colony-forming cells in mice Effect of rate of exposure to ionizing radiation . Radiat Res. 51:1972;374-380.
9. Peters L.J., Withers H.R., Cundiff J.H., et al. Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiobiology. 131:1979;243-247.
10. Barendsen G.W. RBE-LET relationships for different types of lethal radiation damage in mammalian cells Comparison with DNA dsb and an interpretation of differences in radiosensitivity . Int J Radiat Oncol Biol Phys. 66:1994;433-436.
11. Aref A, Mohammad R, Yudelev M; et al. Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines. Radiat Oncol Invest (provisionally accepted).
12. Al-Katib A.M., Smith M.R., Kamanda W.S., et al. Bryostatin 1 down regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. Clin Cancer Res. 4:1998;1305-1314.
13. Nishikori M., Hansen H., Jhanwar S., et al. Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8:14 translocation. Cancer Genet Cytogenet. 12:1984;39-50.
14. Clinical neutron dosimetry, part I. ICRU Report 45;1989.
15. Al-Katib A., Mohammad R., Hamdan M., et al. Propagation of Waldenstrom's macroglobulinemia cells in vitro and in severe combined immune deficient mice Utility as a preclinical drug screening model . Blood. 81:1993;3034-3042.
16. +) neutrons than 4 MEV photons. Int J Radiat Oncol Biol Phys. 28:1994;913-920.
17. Fertil B., Dertinger H., Courdi A., et al. Mean inactivation dose A useful concept for intercomparison of human cell survival curves . Radiat Res. 99:1984;73-84.
18. (p → Be+) neutrons of human cells differing in photon sensitivity. Int J Radiat Biol Phys. 61:1992;805-812.
19. Courdi A., Brassart N., Herault J., et al. The RBE of fast neutrons for in vitro inactivation of human tumour cells determined by the ratio of mean inactivation doses. Acta Oncol. 35:1996;237-242.
20. International Commission on Radiation Units and Measurements, Report 30. Quantitative concepts and dosimetry in radiobiology. Washington; 1979.
21. Pestell K.E., Medlow C.J., Titley J.C., et al. Characterisation of the p53 status, BLC-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines. Int J Cancer. 77:1998;913-918.
22. Evans H.H., Ricanati M., Horng M.F., et al. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains. Mutat Res. 217:1989;53-63.
23. Kelland L.R., Tonkin K.S. In vitro chemosensitivity of four new carcinoma of the cervix cell lines Relationship to radiosensitivity . Eur J Cancer Clin Oncol. 25:1989;1211-1218.
24. Hida T., Ueda R., Takahashi T., et al. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay. Cancer Res. 49:1989;4785-4790.
25. Heenan M., Kavanagh K., Redmond A., et al. Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology. 19:1996;237-242.
26. Miyamoto H. In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells. Acta Med Okayama. 40:1986;75-81.
27. Bergman P.J., Harris D. Radioresistance, chemoresistance, and apoptosis resistance. Vet Clin North Am Small Anim Pract. 27:1997;47-57.
28. Steel G.G., Wheldon T.E. The radiation biology of paediatric tumours. Pinkerton R., Plowman N. Paediatric oncology. 1991;John Wiley, London.
29. Drewinko B., Humphrey R.M., Trujillo J.M. The radiation response of a long-term culture of human lymphoid cells. Int J Radiat Oncol Biol Phys. 21:1972;361-373.
30. Song C.W., Kim T.H., Khan F.M., et al. Radiobiological basis of total body irradiation with different dose rate and fractionation Repair capacity of hemopoietic cells . Int J Radiat Oncol Biol Phys. 7:1981;1695-1701.
31. Aref A, Narayan S, Tekyi-Mensah S; et al. The value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin lymphoma. Radiat Oncol Invest (provisionally accepted).
32. Glick J.H., Kim K., Earle J., et al. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early state non-Hodgkin's lymphoma (NHL). (Proceedings of ASCO) J Clin Oncol. 14:1995;391.
33. Britten R.A., Warenius H.M., White R., et al. Melphalan resistant human ovarian tumour cells are cross-resistant to photons, but not to high LET neutrons. Radiother Oncol. 18:1990;357-363.
34. Veninga T., Tribukait B., Lemstra W., et al. Non-effectivity of roentgen irradiation in an in vivo rapidly growing murine lymphosarcoma. Acta Radiol Oncol. 22:1983;477-485.